+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene



The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene



Protein Science 16(5): 897-905



Lasofoxifene is a new and potent selective estrogen receptor modulator (SERM). The structural basis of its interaction with the estrogen receptor has been investigated by crystallographic analysis of its complex with the ligand-binding domain of estrogen receptor alpha at a resolution of 2.0 A. As with other SERMs, lasofoxifene diverts the receptor from its agonist-bound conformation by displacing the C-terminal AF-2 helix into the site at which the LXXLL motif of coactivator proteins would otherwise be able to bind. Lasofoxifene achieves this effect by occupying the space normally filled by residue Leu 540, as well as by modulating the conformation of residues of helix 11 (His 524, Leu 525). A well-defined salt bridge between lasofoxifene and Asp 351 suggests that charge neutralization in this region of the receptor may explain the some of the antiestrogenic effects of lasofoxifene. The results suggest general features of ERalpha/SERM recognition, and add a new dimension to efforts to rationalize differences between the biological activity profiles exhibited by these important pharmacological agents.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056159167

Download citation: RISBibTeXText

PMID: 17456742

DOI: 10.1110/ps.062729207


Related references

Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. Journal of Biological Chemistry 282(18): 13648-13655, 2007

Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077. Molecular Pharmacology 92(1): 22-29, 2017

Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action. Journal of Medicinal Chemistry 60(20): 8394-8406, 2017

Crystal structure of Abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. Journal of Molecular Biology 281(3): 3-21, 1998

Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. Journal of Molecular Biology 281(3): 513-521, 1998

Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design. Journal of Medicinal Chemistry 51(24): 7768-7776, 2008

Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP. Journal of Biological Chemistry 283(28): 19657-19664, 2008

Crystal structure of human GGA1 GAT domain complexed with the GAT-binding domain of Rabaptin5. EMBO (European Molecular Biology Organization) Journal 23(20): 3909-3917, 2004

Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Science 15(5): 987-999, 2006

Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand. Journal of Experimental Medicine 191(7): 1105-1116, 2000

Crystal structures of the maltodextrin/maltose-binding protein complexed with reduced oligosaccharides: flexibility of tertiary structure and ligand binding. Journal of Molecular Biology 306(5): 1115-1126, 2001

Crystal structure and ligand-binding studies of a screened peptide complexed with streptavidin. Biochemistry 31(39): 9350-9354, 1992

Crystal structure and ligand binding studies of a screened peptide complexed with streptavidin. Biochemistry 31(39): 9350-9354, 1992

Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein. Journal of Biological Chemistry 278(26): 24090-4, 2003

Crystal structure of Gla domain of coagulation factor X complexed with its binding protein. Fibrinolysis & Proteolysis 14(Suppl. 1): 46, 2000